Skip to main content

Peer Review reports

From: Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report

Original Submission
28 Sep 2015 Submitted Original manuscript
3 Oct 2015 Reviewed Reviewer Report - Tomas Kalincik
11 Oct 2015 Reviewed Reviewer Report - Olivier Outteryck
27 Oct 2015 Author responded Author comments - Francesco Patti
Resubmission - Version 2
27 Oct 2015 Submitted Manuscript version 2
7 Nov 2015 Reviewed Reviewer Report - Tomas Kalincik
21 Nov 2015 Reviewed Reviewer Report - Olivier Outteryck
26 Nov 2015 Author responded Author comments - Francesco Patti
Resubmission - Version 3
26 Nov 2015 Submitted Manuscript version 3
Publishing
2 Dec 2015 Editorially accepted
7 Dec 2015 Article published 10.1186/s12883-015-0512-0

You can find further information about peer review here.

Back to article page